Third-Party Tested · Free shipping on orders $150+

Retatrutide

Weight Management

Retatrutide

Next-generation triple agonist

$189.99 ≥ 99.1%● In Stock

Dose

10mg

Purity

≥ 99.1%

Retatrutide is a novel triple agonist peptide investigated for its activity on GLP-1, GIP, and glucagon receptors. Each vial is lyophilized and third-party tested for purity, identity, and endotoxin levels.

1
Lab Verified
Ships 24h
COA Included
For Research Use Only: All products are sold strictly for research, laboratory, and analytical purposes only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease. For qualified researchers and institutions only.

Product details

Research Applications

  • Triple receptor activity studies
  • Metabolic pathway research
  • Lyophilized powder, sealed vial

Storage & Handling

Store lyophilized at -20°C. Once reconstituted, refrigerate at 2–8°C.

Quality Assurance

Independently tested by accredited labs. Full Certificate of Analysis (COA) with HPLC, mass-spec, and endotoxin data shipped with every order.

View sample COA →

You may also like

Semaglutide ≥ 99.2%

Weight Management

Semaglutide

5mg · GLP-1 receptor agonist

$149.99
Tirzepatide ≥ 99.4%

Weight Management

Tirzepatide

10mg · Dual GIP / GLP-1 agonist

$169.99